High and low doses with increased IMT, moderate (0.15–0.4 mg/kg/day) doses with decreased IMT in children [26] and adults [27] IMT: Intima-media thickness; SLE: Systemic lupus erythematosus.

MI 2 Mott Children's Hospital, Department of Pediatrics, Division of Neonatal-Perinatal Medicine, Ann Arbor, MI Systemic lupus erythematosus (SLE) research has focused primarily on adaptive immunity.

Having lupus may increase your risk of food allergies. And certain foods may trigger lupus flares. Learn more.

In a new study, researchers examined children with childhood-onset systemic lupus erythematosus (cSLE) and the association between race and social determinants of health (SDOH) on the individual or ...

There are no significant differences in outcomes post-AMI in patients with systemic lupus erythematosus vs the general population.

Immune cells called monocytes produce a key inflammatory protein called interleukin-1 beta (IL-1β) through an unconventional ...

Doctors in China said a homegrown cell therapy saw initial success in children with a severe autoimmune disorder, the latest ...

Doctors in Hangzhou, Zhejiang province, have successfully completed the world's largest clinical study of involving the use ...

Adult patients hospitalized for aseptic or septic revision TKA were eligible for inclusion. Patients with SLE were propensity score matched in a 1:4 ratio with individuals without the disease. The ...

The trial met its primary composite endpoint demonstrating significant clinical improvement with dapirolizumab pegol vs placebo in patients with moderate to severe SLE. Topline results were ...

have successfully completed the world's largest clinical study of involving the use of CAR-T cell therapy to treat children with systemic lupus erythematosus. The study saw 20 children with the ...